Your browser doesn't support javascript.
loading
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.
Marone, Romina; Landmann, Emmanuelle; Devaux, Anna; Lepore, Rosalba; Seyres, Denis; Zuin, Jessica; Burgold, Thomas; Engdahl, Corinne; Capoferri, Giuseppina; Dell'Aglio, Alessandro; Larrue, Clément; Simonetta, Federico; Rositzka, Julia; Rhiel, Manuel; Andrieux, Geoffroy; Gallagher, Danielle N; Schröder, Markus S; Wiederkehr, Amélie; Sinopoli, Alessandro; Do Sacramento, Valentin; Haydn, Anna; Garcia-Prat, Laura; Divsalar, Christopher; Camus, Anna; Xu, Liwen; Bordoli, Lorenza; Schwede, Torsten; Porteus, Matthew; Tamburini, Jérôme; Corn, Jacob E; Cathomen, Toni; Cornu, Tatjana I; Urlinger, Stefanie; Jeker, Lukas T.
  • Marone R; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Landmann E; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Devaux A; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Lepore R; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Seyres D; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Zuin J; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Burgold T; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Engdahl C; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Capoferri G; Cimeio Therapeutics AG , Basel, Switzerland.
  • Dell'Aglio A; Ridgeline Discovery GmbH , Basel, Switzerland.
  • Larrue C; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Simonetta F; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Rositzka J; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Rhiel M; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Andrieux G; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Gallagher DN; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Schröder MS; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Wiederkehr A; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Sinopoli A; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Do Sacramento V; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Haydn A; Department of Biomedicine, Basel University Hospital and University of Basel, Basel, Switzerland.
  • Garcia-Prat L; Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.
  • Divsalar C; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland.
  • Camus A; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
  • Xu L; Department of Medicine, Translational Research Center for Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Bordoli L; Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg , Freiburg, Germany.
  • Schwede T; Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Porteus M; Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg , Freiburg, Germany.
  • Tamburini J; Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Corn JE; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg , Freiburg, Germany.
  • Cathomen T; Department of Biology, Institute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
  • Cornu TI; Department of Biology, Institute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
  • Urlinger S; Ridgeline Discovery GmbH , Basel, Switzerland.
  • Jeker LT; Ridgeline Discovery GmbH , Basel, Switzerland.
J Exp Med ; 220(12)2023 12 04.
Article en En | MEDLINE | ID: mdl-37773046
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Subunidad alfa del Receptor de Interleucina-3 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Subunidad alfa del Receptor de Interleucina-3 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article